ArticleMedical science monitor : international medical journal of experimental and clinical research2019

Everolimus Reverses Palbociclib Resistance in ER+ Human Breast Cancer Cells by Inhibiting Phosphatidylinositol 3-Kinase(PI3K)/Akt/Mammalian Target of Rapamycin (mTOR) Pathway.

Lin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.